http://bmj.com/cgi/content/full/323/7319/956/d
|
|||||
|
|
Judy Siegel-Itzkovich Jerusalem
Tobacco company executives who market their cigarettes in Israel as
"lite," "low tar," "mild," or "low
nicotine" could face a prison sentence of one to two years.
This is the prescribed but little used punishment for violation of the 1981
Consumer Protection Law, which is the basis for a criminal investigation just
launched by the ministry of commerce and industry against cigarette
manufacturers and importers. They are suspected of misleading the public into
believing that this form of tobacco is "safer" than ordinary
cigarettes.
The investigation was initiated after the filing of a lawsuit in the
Jerusalem district court last June by lawyers for Clalit Health Services,
Israel’s largest public health fund. They asked for an injunction to prevent
cigarette manufacturers and importers from using the terms "light,"
"mild," "low tar," and "low nicotine" to describe
and market their products.
The health fund argued that these terms were misleading because tobacco
companies themselves had in several forums admitted that cigarettes with less
tar or nicotine were no less dangerous to health. The court has not yet ruled
in the case, but the ministry was pressed into taking action on its own by the
lawyers’ request for an injunction and efforts by the Israel Consumer Council.
As many as half of all cigarette sales in Israel are of "lite" or
similarly "reduced" brands. Marlboro Lights, made by Philip Morris,
is the most popular brand sold in the Israel Defence Forces’ kiosks frequented
by soldiers.
The European parliament recently recommended to its 15 member governments
that tobacco companies be barred from using such terms on the grounds that they
falsely suggest lower toxicity, but its recommendations are not due to come
into effect until 2003.
Brazil was the first country in the world to put such a prohibition into
force, followed by Canada. Israel could be the third to do so, said Amos
Hausner and Lipa Meir, lawyers for Clalit Health Services.
The lawyers are also seeking nearly £1.3bn ($2bn) on behalf of the health
fund in compensation for its huge expenses in treating smokers who become ill.
Mr Hausner said that this was the first time anywhere in the world that a
criminal investigation had been launched against tobacco companies suspected of
defrauding the public by using misleading advertising terms.
Foreign brands being sold in Israel include L&M Lites and brands of the
Brown & Williamson and British American Tobacco companies, and the Israeli
tobacco company Dubek produces Time Lite and Golf.
The lawyers for Clalit Health Services presented documents to the court in
which tobacco companies had conceded that lower tar and lower nicotine
cigarettes were not "safer" than ordinary cigarettes and that
cigarettes that are "mild" emitted higher concentrations of toxic
substances than those that are not. A Canadian survey of smokers recently
showed that most of them bought mild cigarettes because they thought they posed
less of a health danger.
Dr Yitzhak Peterburg, director general of Clalit Health Services, maintained
that many smokers were "tricked" into thinking that if they smoked
mild or lite cigarettes, they enjoyed "health benefits." But that was
not true, he said, and the companies had used these false messages to dupe the
public. Children and teenagers were most easily lured into smoking by these
brands, he said, adding that he hoped that an end to misleading advertising and
marketing would reduce sales and damage from smoking.
A statement by David Kessler, a former commissioner of the US Food and Drug
Administration and author of a recent book on the tobacco industry called A
Question of Intent, was presented to the district court. He wrote that
smokers of mild or lite cigarettes did not realise these caused just as much
nicotine to be absorbed by their body as other cigarettes.
Asked to comment, a spokeswoman for Dubek, Hava Barak, claimed that the
tobacco company had "never used health claims for using its ‘lite’
brands" and that it regarded the term "solely as a definition of the
taste of the cigarette."
The Eliachar tobacco importing company commented that terms
such as "ultra-light" and "full flavor" were mere
"descriptors and facilitate consumers’ ability to distinguish among
different product offerings."
ALL INFORMATION, DATA,
AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR
OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING
MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN
IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN
CONSULTATION WITH YOUR HEALTH CARE PROVIDER.
|
|
|
|